데이터가 없습니다.

1. Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2024.03.05
2. Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial [ AMERICAN HEART JOURNAL ] - 2024.03.01
3. Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial [ EUROPEAN HEART JOURNAL ] - 2024.03.01
4. Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular Ultrasound [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2024.01.23
5. Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease [ JACC-CARDIOVASCULAR INTERVENTIONS ] - 2024.01.08
6. Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve Replacement [ JACC-CARDIOVASCULAR INTERVENTIONS ] - 2023.12.25
7. Age- and Sex-Specific Disparities in Outcomes After Ticagrelor Versus Clopidogrel in East Asian Patients [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2023.11.15
8. Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical Trial [ CIRCULATION ] - 2023.10.17
9. Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2023.09.15
10. Impact of Optimal Medical Therapy on Long-Term Outcomes After Myocardial Revascularization for Multivessel Coronary Disease. [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2023.09.15
11. Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease [ REVISTA ESPANOLA DE CARDIOLOGIA ] - 2023.04.01
12. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Revascularization of Left Main Coronary Artery Disease [ Korean Circulation Journal ] - 2023.03.01
13. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial. [ CIRCULATION ] - 2022.11.22
14. Association of aortic valvular complex calcification burden with procedural and long-term clinical outcomes after transcatheter aortic valve replacement. [ European Heart Journal-Cardiovascular Imaging ] - 2022.10.20
15. Inter-racial differences in patients undergoing transcatheter aortic valve implantation [ HEART ] - 2022.09.21
16. Routine Functional Testing or Standard Care in High-Risk Patients after PCI. [ NEW ENGLAND JOURNAL OF MEDICINE ] - 2022.09.08
17. Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. [ CIRCULATION ] - 2022.08.09
18. Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial. [ AMERICAN HEART JOURNAL ] - 2022.05.01
19. Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2022.04.05
20. Time-Dependent Impact of Sex on the Long-Term Outcomes After Left Main Revascularization. [ JOURNAL OF THE AMERICAN HEART ASSOCIATION ] - 2022.03.01
21. Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement. [ JOURNAL OF THE AMERICAN HEART ASSOCIATION ] - 2022.02.15
22. Racial Differences in the Incidence and Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement [ JACC-CARDIOVASCULAR INTERVENTIONS ] - 2021.12.27
23. Long-Term Outcomes After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents or Coronary Artery Bypass Grafting for Multivessel Coronary Disease [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2021.12.01
24. Ten-year outcomes of early generation sirolimus- versus paclitaxel-eluting stents in patients with left main coronary artery disease [ CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS ] - 2021.11.01
25. Long-Term Clinical Impact of Intravascular Ultrasound Guidance in Stenting for Left Main Coronary Artery Disease [ CIRCULATION-CARDIOVASCULAR INTERVENTIONS ] - 2021.10.14
26. Comparison of Long-Term Outcomes Following Coronary Revascularization in Men-vs-Women with Unprotected Left Main Disease [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2021.08.15
27. Incidence, Predictors, and Prognostic Impact of Immediate Improvement in Left Ventricular Systolic Function After Transcatheter Aortic Valve Implantation [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2021.08.01
28. Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study [ JOURNAL OF THE AMERICAN HEART ASSOCIATION ] - 2021.07.20
29. Prognostic Effect of the SYNTAX Score on 10-Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial [ JOURNAL OF THE AMERICAN HEART ASSOCIATION ] - 2021.07.20
30. Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease. [ CANADIAN JOURNAL OF CARDIOLOGY ] - 2021.05.21
31. Revascularization or medical therapy for stable coronary artery disease: To do or not to do, that is the question [ INTERNATIONAL JOURNAL OF CARDIOLOGY ] - 2021.04.15
32. Comparison of simple versus complex stenting in patients with true distal left main bifurcation lesions [ CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS ] - 2021.04.01
33. Prognostic Value of Baseline Sarcopenia on 1-year Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2021.01.15
34. Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement [ BMJ OPEN ] - 2021.01.05
35. Prevalence, predictors, prognostic significance, and effect of techniques on outcomes of coronary lesion calcification following implantation of drug-eluting stents: a patient-level pooled analysis of stent-specific, multicenter, prospective IRIS-DES registries [ CORONARY ARTERY DISEASE ] - 2021.01.01
36. Long-Term Outcomes After PCI or CABG for Left Main Coronary Artery Disease According to Lesion Location [ JACC-CARDIOVASCULAR INTERVENTIONS ] - 2020.12.28
37. Delay, Death, and Heterogeneity of Primary PCI During the COVID-19 Pandemic An International Perspective [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2020.11.17
38. Incidence and Impact of Thrombocytopenia in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2020.11.01
39. Comparison of optical coherence tomography-guided versus intravascular ultrasound-guided percutaneous coronary intervention: Rationale and design of a randomized, controlled OCTIVUS trial [ AMERICAN HEART JOURNAL ] - 2020.10.01
40. Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2020.09.22
41. Practice Pattern, Diagnostic Yield, and Long-Term Prognostic Impact of Coronary Computed Tomographic Angiography [ JOURNAL OF THE AMERICAN HEART ASSOCIATION ] - 2020.09.15
42. Clinical outcomes of contemporary drug-eluting stents in patients with and without diabetes mellitus: Multigroup propensity-score analysis using data from stent-specific, multicenter, prospective registries [ CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS ] - 2020.08.01
43. Pragmatic Trial Comparing Routine Versus No Routine Functional Testing in High-Risk Patients Who Underwent Percutaneous Coronary Intervention: Rationale and Design of POST-PCI Trial [ AMERICAN HEART JOURNAL ] - 2020.06.01
44. Bioresorbable Vascular Scaffolds Versus Drug-Eluting Stents for Diffuse Long Coronary Narrowings [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2020.06.01
45. Prognostic Value of Resting Distal-to-Aortic Coronary Pressure in Clinical Practice [ CIRCULATION-CARDIOVASCULAR INTERVENTIONS ] - 2020.05.05
46. Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2020.05.01
47. Long-Term (10-Year) Outcomes of Stenting or Bypass Surgery for Left Main Coronary Artery Disease in Patients With and Without Diabetes Mellitus [ JOURNAL OF THE AMERICAN HEART ASSOCIATION ] - 2020.04.21
48. Rates and Independent Correlates of 10-Year Major Adverse Events and Mortality in Patients Undergoing Left Main Coronary Arterial Revascularization [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2020.04.15
49. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease [ JACC-CARDIOVASCULAR INTERVENTIONS ] - 2020.02.10
50. Nutritional status and risk of all-cause mortality in patients undergoing transcatheter aortic valve replacement assessment using the geriatric nutritional risk index and the controlling nutritional status score [ CLINICAL RESEARCH IN CARDIOLOGY ] - 2020.02.01
51. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management A Randomized Clinical Trial [ CIRCULATION ] - 2019.12.03
52. Long-term 10-year outcomes of stenting or bypass surgery for acute coronary syndromes and stable ischemic heart disease with unprotected left main coronary artery disease [ AMERICAN HEART JOURNAL ] - 2019.12.01
53. Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk, Elderly Patients With Severe Aortic Stenosis [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2019.09.17
54. Effect of Age and Sex on Outcomes After Stenting or Bypass Surgery in Left Main Coronary Artery Disease [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2019.09.01
55. Long-term trends of treatment effect of stenting or bypass surgery in patients with ostial or shaft left main coronary artery disease [ CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS ] - 2019.09.01
56. Safety and Effectiveness of Contemporary P2Y12 Inhibitors in an East Asian Population With Acute Coronary Syndrome: A Nationwide Population-Based Cohort Study. [ JOURNAL OF THE AMERICAN HEART ASSOCIATION ] - 2019.07.16
57. Contemporary state-of-the-art PCI with functional and imaging concepts: forethoughts on the FAME 3 trial [ EUROINTERVENTION ] - 2019.06.12
58. Comparative effectiveness of different contemporary drug-eluting stents in routine clinical practice: a multigroup propensity score analysis using data from the stent-specific, multicenter, prospective registries [ CORONARY ARTERY DISEASE ] - 2019.06.01
59. Differential cutoff points and clinical impact of stent parameters of various drug-eluting stents for predicting major adverse clinical events: An individual patient data pooled analysis of seven stent-specific registries and 17,068 patients [ INTERNATIONAL JOURNAL OF CARDIOLOGY ] - 2019.05.01
60. Time- and Dose-Dependent Association of Statin Use With Risk of Clinically Relevant New-Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study. [ JOURNAL OF THE AMERICAN HEART ASSOCIATION ] - 2019.04.16
61. Incidence, Predictors, Management, and Clinical Significance of New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2019.04.01
62. Relation of Body Mass Index to Risk of Death or Stroke in Patients Who Underwent Transcatheter Aortic Valve Implantation [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2019.02.15
63. Temporal changes in characteristics, treatment strategies, and outcomes of coronary bifurcation lesion interventions [ CORONARY ARTERY DISEASE ] - 2019.01.01
64. Outcomes After Use of Standard- and Low-Dose Non-Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation [ STROKE ] - 2019.01.01
65. 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2018.12.11
66. The authors reply: Treatment of patients with restenosis of drug-eluting stents [ AMERICAN HEART JOURNAL ] - 2018.11.01
67. Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea [ KOREAN JOURNAL OF INTERNAL MEDICINE ] - 2018.09.01
68. Percutaneous coronary intervention in left main disease: SYNTAX, PRECOMBAT, EXCEL and NOBLE-combined cardiology and cardiac surgery perspective [ ANNALS OF CARDIOTHORACIC SURGERY ] - 2018.07.01
69. Effect of Low-Dose Versus Standard-Dose Ticagrelor and Clopidogrel on Platelet Inhibition in Acute Coronary Syndromes [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2018.04.10
70. Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: A randomized RESTORE trial [ AMERICAN HEART JOURNAL ] - 2018.03.01
71. Safety and Effectiveness of Second-Generation Drug-Eluting Stents in Patients With Left Main Coronary Artery Disease [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2018.02.27
72. Generalizability of EXCEL and NOBLE results to a large registry population with unprotected left main coronary artery disease [ CORONARY ARTERY DISEASE ] - 2017.12.01
73. Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice [ KOREAN JOURNAL OF INTERNAL MEDICINE ] - 2017.09.01
74. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions [ JACC-CARDIOVASCULAR INTERVENTIONS ] - 2017.08.14
75. Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease [ CORONARY ARTERY DISEASE ] - 2017.08.01
76. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials [ JACC-CARDIOVASCULAR INTERVENTIONS ] - 2017.07.24
77. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication Insights From a Large Intern [ Circulation-Cardiovascular Interventions ] - 2017.07.01
78. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents [ JACC-CARDIOVASCULAR INTERVENTIONS ] - 2017.06.12
79. Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left [ Circulation-Cardiovascular Interventions ] - 2017.06.01
80. Nicorandil for maximal hyperemia: a theoretical advantage awaiting clinical significance. [ CORONARY ARTERY DISEASE ] - 2017.03.01
81. Reply: The Unforgettable Cornerstone: Role of Ticlopidine in Developing Current Antithrombotic Treatment After Percutaneous Coronary Intervention. [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2017.02.14
82. Temporal Changes in Outcomes After Stenting or Bypass Surgery for Unprotected Left Main Coronary Artery Disease According to Diabetes Status [ JACC-CARDIOVASCULAR INTERVENTIONS ] - 2016.12.26
83. Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes. [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2016.09.13
84. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents [ AMERICAN HEART JOURNAL ] - 2016.09.01
85. Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations. [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2016.06.21
86. Clinical application and potential effects of 2014 hypertension guidelines on incident cardiovascular events [ AMERICAN HEART JOURNAL ] - 2015.11.01
87. Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events [ AMERICAN HEART JOURNAL ] - 2015.09.01
88. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction [ JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION ] - 2014.11.19
89. Sex difference in clinical outcomes after percutaneous coronary intervention in Korean population [ AMERICAN HEART JOURNAL ] - 2014.05.01
90. Impact of the Angiographic Mechanisms Underlying Periprocedural Myocardial Infarction After Drug-Eluting Stent Implantation [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2014.04.01
91. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention. [ EUROPEAN HEART JOURNAL ] - 2013.06.01
92. Association of Body Mass Index With Major Cardiovascular Events and With Mortality After Percutaneous Coronary Intervention [ Circulation-Cardiovascular Interventions ] - 2013.04.01
93. Differential prognostic impact of high on-treatment platelet reactivity among patients with acute coronary syndromes versus stable coronary artery disease undergoing percutaneous coronary intervention [ AMERICAN HEART JOURNAL ] - 2013.01.15
94. Long-Term Outcome of Stents Versus Bypass Surgery in Diabetic and Nondiabetic Patients With Multivessel or Left Main Coronary Artery Disease: A Pooled Analysis of 5775 Individual Patient Data. [ Circulation-Cardiovascular Interventions ] - 2012.08.01
95. Outcomes After Unrestricted Use of Everolimus-Eluting and Sirolimus-Eluting Stents in Routine Clinical Practice: A Multicenter, Prospective Cohort Study [ Circulation-Cardiovascular Interventions ] - 2012.06.01
96. A Point-of-Care Platelet Function Assay and C-Reactive Protein for Prediction of Major Cardiovascular Events After Drug-Eluting Stent Implantation [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2011.12.23
97. Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Long Coronary Artery Lesions(A Randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial) [ JACC Cardiovascular Interventions ] - 2011.10.01
98. Complexity of Atherosclerotic Coronary Artery Disease and Long-Term Outcomes in Patients With Unprotected Left Main Disease Treated With Drug-Eluting Stents or Coronary Artery Bypass Grafting [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2011.05.01
99. Left Main Stenting - Now and Future [ CIRCULATION JOURNAL ] - 2011.04.01
100. Clinical Outcome, Angiographic Outcome, and Coronary Endothelial Function After Drug-Eluting Stent Implantation Reply [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2011.04.01
101. Long-Term Comparison of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization 5-Year Outcomes From the Asan Medical Center-Multivessel Revascularization Registry [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2011.01.11
102. Long-Term Outcomes After Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease 10-Year Results of Bare-Metal Stents and 5-Year Results of Drug-Eluting Stents From the ASAN-MAIN Registry [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2010.10.19
103. Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization. The ZEST(Comparison of the the Efficacy and Safety of Zotarolimus-Eluting Stent with Sirolimus-Eluting and PacliTaxel-Eluting Stent [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2010.10.01
104. LongTerm Outcomes After Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease(10-Year Results of Bare-Metal Stents and 5-Year Results of Drug-Eluting Stents From the ASAN–MAIN(ASAN Medical Center–Left MAIN [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2010.10.01
105. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation [ CIRCULATION ] - 2009.11.17
106. Prognostic Influence of Diabetes Mellitus on Long-Term Clinical Outcomes and Stent Thrombosis After Drug-Eluting Stent Implantation in Asian Patients [ AMERICAN JOURNAL OF CARDIOLOGY ] - 2009.03.01
107. Two-Year Follow-Up of the Quantitative Angiographic and Volumetric Intravascular Ultrasound Analysis After Nonpolymeric Paclitaxel-Eluting Stent Implantation: Late “Catch-Up” Phenomenon From ASPECT Study [ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ] - 2006.12.19

1. 동맥경화성 심혈관질환 (ASCVD)의 기록된 과거력이 있는 환자에서 지단백(a) 수치의 분포 특성을 규명하기 위한 다기관, 횡단 연구 - 2022.06.23 ~ 2023.04.30
2. 경피적대동맥판막치환술의 치료 효과와 비용 효과를 위한 후향적 관찰연구 - 2022.06.01 ~ 2022.12.31
3. 대퇴동맥 접근법을 이용한 경피적 대동맥 판막 삽입술(TAVR)을 시행한 중증 대동맥판막 협착증 환자를 대상으로 대뇌색전보호장치(Sentinel)의 유효성과 안전성을 평가하기 위한 다기관, 단일군, 대조 공개 임상연구 - 2022.02.07 ~ 2024.03.31
4. 경피적대동맥판막치환술의 치료 효과와 비용 효과를 위한 후향적 관찰연구 - 2021.09.01 ~ 2022.05.31
5. 경피적 대동맥 판막 치환술을 받은 환자 모집을 통한 다국적, 다기관 전향적 등록관찰 연구 - 2020.10.19 ~ 2034.12.31
6. 승모판막 역류 환자를 대상으로 Mitraclip을 이용한 경피적 승모판막 성형술의 안전성과 유효성을 평가하기 위한 전향적, 단일기관, 단일군, 비대조, 공개 임상연구 - 2020.08.03 ~ 2024.07.31
7. 얼티매스터 탄세이(UltimasterTM TanseiTM ) 스텐트의 효과와 안전성 평가를 위한 다 기관, 전향적 등록관찰연구 - 2020.07.10 ~ 2026.12.31
8. 경피적 관상동맥 중재술 (PCI)을 받은 ST 분절 상승 심근경색증 (STEMI) 환자에 대한 BioFreedom™ BA9™ 관상동맥용 약물코팅 스텐트의 아시아인 레지스트리 연구 - 2019.01.03 ~ 2020.12.31
9. 급성 관상동맥 증후군이 있는 시험대상자에서 CSL112의 유효성 및 안전성을 연구하기 위한 제3상, 다기관, 이중 눈가림, 무작위배정, 위약 대조, 평행군 시험 - 2018.06.28 ~ 2023.08.06
10. 심방 세동에서 경도관 대동맥 판막 삽입술을 받은 환자들의 에독사반 대 표준 치료 및 이들이 임상 결과에 미치는 영향 - 2018.06.11 ~ 2020.12.31
11. 고위험 관상동맥 중재술을 시행한 환자에서 초기 강화 및 후기 약화의 맞춤형 항혈소판 치료와 표준 이중 항혈소판 치료의 비교 - 2018.05.11 ~ 2022.04.30
12. 파이어호크 스텐트의 효과와 안전성 평가를 위한 다 기관, 전향적 등록관찰연구 - 2018.02.01 ~ 2024.06.30
13. 심혈관 위험인자 및 중등도 신기능 장애가 있는 제 2형 당뇨병 환자에서 소타글리플로진이 심혈관 및 신장 사건에 미치는 영향을 입증하기 위한 무작위배정 이중 눈가림 위약 대조 평행군 다기관 시험 - 2017.12.18 ~ 2022.08.31
14. 경피적 대동맥판막 교환술 시행 후 판엽 혈전증 및 뇌색전증 예방에 대한 항응고제와 이중 항혈소판제의 효능 비교 연구 - 2017.11.22 ~ 2020.12.31
15. 바이오프리덤 스텐트의 효과와 안전성 평가를 위한 다 기관 전향적 등록관찰연구 - 2017.07.14 ~ 2023.12.31
16. 긴 관상동맥 병변에서 에버롤리무스 방출 생체 흡수형 혈관스캐폴드와 에버롤리무스 방출 금속 스텐트 치료 후 임상적 경과에 대한 무작위 통제 비교 연구 - 2017.06.15 ~ 2020.05.30
17. 생체 흡수형 혈관 스캐폴드 삽입에 있어 시술 전 광학 간섭 단층촬영의 임상적 중요성에 대한 연구: 전향적 다기관 무작위 배정 연구 - 2017.06.04 ~ 2020.05.30
18. 미만성 긴 관상동맥 질환에 에베롤리무스 생체흡수형 스카폴드와 에베롤리무스-방출 금속 스텐트 간의 유효성 및 안전성에 관한 연구( ABSORB-LONG) - 2016.08.04 ~ 2023.12.31
19. 급성 관상동맥 증후군이 있는 시험대상자에서 Clopidogrel 또는 Ticagrelor 요법에 추가한 Rivaroxaban 대 Acetylsalicylic Acid의 안전성을 비교하기 위한 무작위 배정, 이중-눈가림, 이중-위약, 활성-대조, 평행군, 다기관 임상시험 - 2015.04.06 ~ 2017.12.31
20. 관상동맥 CT을 이용한 한국형 심혈관질환 위험도 예측 모델 구축 및 임상 적용 - 2015.01.23 ~ 2016.12.31
21. 맞춤형 관상동맥 CT스캔 수행을 위한 한국형 심혈관질환 위험도 예측 모델 구축 및 임상 적용 - 2015.01.01 ~ 2015.08.31
22. 맞춤형 관상동맥 CT스캔 수행을 위한 한국형 심혈관질환 위험도 예측 모델 구축 및 임상 적용 - 2014.01.01 ~ 2014.12.31

데이터가 없습니다.

      데이터가 없습니다.

 공지